POSTER SESSIONS ABSTRACTS
Poster Session V (B)
P-5B
PHARMACOLOGY OF THE NERVOUS SYSTEM (PART 2)
| P-5/42 | Neuroprotective effects of memantine and topiramate combined with
hypothermia in hypoxic-ischemic neonatal brain injury E. Landucci, E. Gerace, T. Scartabelli, L. Filippi, G. la Marca, R. Guerrini, D. Pellegrini-Giampietro (Firenze) |
| P-5/43 | Idiopathic hemifacial spasm
responsive to zonisamide. A. Siniscalchi, L. Gallelli, C. Palleria, A. Squillace , G. De Sarro (Cosenza, Catanzaro) |
| P-5/44 | Preconditioning with NMDA and DHPG
induces ischemic tolerance with differential mechanisms in an in vitro hippocampal slice model. E. Gerace, E. Zianni, E. Landucci, F. Gardoni, T. Scartabelli, G. Mannaioni, F. Moroni, M. Di Luca, D. Pellegrini-Giampietro (Firenze, Milano) |
| P-5/45 | Microglia-derived microvesicles convert Ab1-42 amyloid peptide
from inert to neurotoxic C. Verderio, E. Turola, A. Bergami, G. Comi, G. Magnani, G. Martino, R. Furlan, M. Matteoli (Milano) |
| P-5/46 | Glutamatergic
alterations and mitochondrial impairment in a murine
model of Alzheimer’s disease A. Romano, T. Cassano, P. Dipasquale, S. Cianci, A. Petrella, S. Cimino, S. Gaetani, V. Cuomo (Roma, Foggia, Roma, Bari, Foggia, Bari) |
| P-5/47 | Role of the
endocannabinoid system in a pharmacological model of
absence epilepsy R. Colangeli, S. Cianci, R.T. Ngomba, J. Mairesse, S. Gaetani, V. Cuomo (Roma, Roma, Bari, Pozzilli, Isernia, Lille, Francia) |
| P-5/48 | Functional antagonism between Nociceptin Orphanin FQ (N/OFQ) and Corticotropin-Releasing
Factor (CRF) in anxiety-related behaviour in rats: involvement of the
central serotonergic system V. Ruggieri, M. Filaferro, G. Vitale, C. Novi (Modena) |
| P-5/49 | The kynurenine
pathway in human neuroblastoma SH-SY5Y cells: regulation by pro-inflammatory
cytokines S. Alboni, C. Benatti, C. Montanari, C. Valensisi, F. Tascedda, C.M. Pariante, N. Brunello (Modena, Londra) |
| P-5/50 | Prolyl endopeptidase (Prep) regulates glucose sensing of VMN
neurons, glucose metabolism and rebound feeding G. D’Agostino, ZW. Liu, R. Meli, A. Calignano, S. Wardlaw , XB. Gao, T.L. Horvath, S. Diano (Naples, New Haven, CT-USA, New York -USA) |
| P-5/51 | Palmitoylethanolamide
is able to attenuate astrocyte activation and neuroinflammation in an in vivo model of Alzheimer’s disease C. Scuderi, M. Valenza, P. Ratano, A. Steardo, G. Esposito, P. Campolongo, M.R. Carratù, L. Steardo (ROME, BARI) |
| P-5/52 | Intestinal dysmotility and enteric neurochemical changes
following nigrostriatal dopaminergic denervation in the rat: relevance to the
gastrointestinal dysfunction associated with Parkinson’s disease F. Blandini, M. Colucci, M. Cervio, G. Levandis, B. Balestra, C. Tassorelli, O. Pastoris, G. Nappi, R. De Giorgio, M. Tonini (Pavia, Bologna) |
| P-5/53 | Activity-dependent
synaptic plasticity and ADAM10 trafficking E. Marcello, F. Gardoni, H. Vara-Rivera, F. Cattabeni, M. Giustetto , I. Perez-Otaño , M. Di Luca (Milano, Alicante, Torino, Pamplona) |
| P-5/54 | Olanzapine in the treatment of anorexia nervosa: a case report W. Milano, G. Nolfe, L. Milano, C. Petrella, A. Capasso (Napoli, Salerno) |
| P-5/55 | Migraine and
Coronary Artery Disease: an Open Study on the Genetic polymorphism of the 5, 10
methylenetetrahydrofolate (MTHFR) and angiotensin I-converting enzyme (ACE)
genes V. Pizza, A. Agresta, A. Bisogno, A. Capasso (Vallo della Lucania (SA), Salerno) |
| P-5/56 | Analysis of MiRNome expression profiles in hippocampus of rats
treated with different antidepressants M. Pelizzari, D. Tardito, A. Mallei, S. Corna , G. Treccani, L. Bocchio-Chiavetto, G. Racagni, M. Popoli (Milano, Brescia) |
| P-5/57 | Beneficial effects of Nandrolone
against disuse-induced muscle atrophy in the hindlimb-unloaded mouse J-F. Desaphy, S. Pierno, A. Liantonio, M. De Bellis, G.M. Camerino, M.M. Dinardo, G. Gramegna, A. Scaramuzzi, D. Conte Camerino (Bari) |
| P-5/58 | Toward the
identification of drug targets for contrasting in vivo muscle fatigability in
muscular dystrophy: potential role of PGC-1α G.M. Camerino, R.F. Capogrosso, A. Cozzoli, M.M. Dinardo, V. Sblendorio, A. Scaramuzzi, A. De Luca (Bari) |
| P-5/59 | MPP+ modulates hyperpolarization-activated
current (Ih) in dopaminergic neurons of the substantia nigra pars compacta. A. Masi, R. Narducci, F. Moroni, G. Mannaioni (Firenze) |
| P-5/60 | Factor XIII Val
34 Leu polymorphism in migraine and cardiovascular disease V. Pizza, A. Agresta, A. Bisogno, A. Capasso (Vallo della Lucania (SA), Vallo della Lucania (SA9, Salerno) |
| P-5/61 | Elderly
Patients with Migraine: an Open-Label Study on Prophylaxis Therapy with
Levetiracetam V. Pizza, A. Agresta, A. Bisogno, A. Capasso (Vallo della Lucania (SA), Vallo della Lucania (SA9, Salerno) |
| P-5/62 | Polymorphism gene
apolipoprotein E in migraine and cardiovascular disease. V. Pizza, A. Agresta, A. Bisogno, A. Capasso (Vallo della Lucania (SA), Salerno) |
| P-5/63 | Paired Oxidative Balance in
Parkinson’s Disease: the Evidence from d-ROMs test and BAP test. V. Pizza, E.L. Iorio, A. Capasso (Vallo della Lucania (SA), Salerno) |
| P-5/64 | Role of deregulation of calcium homeostasis in glial cells in an
innovative model of Alzheimer’s disease A. Grolla, D. Lim, G. Balzaretti, G. Fakhfouri, E. Marcello, M. Di Luca, PL. Canonico, A.A. Genazzani (Novara, Milano) |
| P-5/65 | Chronic
treatment with ethinyl estradiol, levonorgestrel or Cetrorelix decreases
brain neurosteroid levels and selectively alters GABAA receptor
plasticity R. Berretti, P. Porcu, F. Santoru, L. Loche , A. Corona, A. Locci, M.C. Mostallino, C. Sogliano, A. Concas (Cagliari) |
| P-5/66 | Decreased allopregnanolone induced
by oral contraceptives is associated with a reduction in social behavior and
sexual motivation in female rat. F. Santoru, R. Berretti, P. Porcu, L. Loche , A. Corona, A. Locci, A. Concas (Cagliari) |
| P-5/67 | Amyloid beta-degrading action of
matrix metalloproteases-2 and -9 contributes to the neuroprotective effect of
estrogen. S. Merlo, M.A. Sortino (Catania) |
| P-5/68 | Human PrP90-231-induced cell death
is associated with intracellular accumulation of insoluble and
protease-resistant macroaggregates and lysosomal dysfunction S. Thellung, A. Corsaro, V. Villa , T. Florio (Genova) |
| P-5/69 | EFFECT OF
CannaBiNOIDS in b-Amyloyd-induced toxicityin
vitro T. Iuvone, D. De Filippis, M. Cipriano, A. Russo, G. Russo, E. Esposito, V. Di Marzo, L. Steardo (Naples, Rome) |
| P-5/70 | The γ-secretase modulator CHF5074 elicits neuroprotection and
increases histone acetylation in primary cortical neurons exposed to oxygen
glucose deprivation V. Porrini, I. Sarnico, A. Lanzillotta, C. Branca, M. Benarese, PF. Spano, B.P. Imbimbo, M. Pizzi (Brescia, Parma) |
| P-5/71 | Targeting epigenetic regulation of NF-KappaB and histones in the therapy
of post-ischemic brain injury C. Branca, A. Lanzillotta, I. Sarnico, M. Benarese, G. Pignataro, O. Cuomo, L. Annunziato, G. Faraco, F. Blasi, A. Chiarugi, PF. Spano, M. Pizzi (Brescia, Napoli, Firenze) |
| P-5/72 | The novel
selective PDE4D inhibitor GEBR-7b increases hippocampal cAMP and enhances memory without emetic effects A. Cavallero , E. Gardella , C. Brullo, E. Canepa, O. Bruno , J. Prickaerts, L.A. Parker , R. Ricciarelli, E. Fedele (Genoa, Maastricht, Guelph) |
| P-5/73 | An integrated pipeline for the identification of novel GPCR
ligands: lessons from GPR17, a promising therapeutic target for
neurodegenerative diseases C. Parravicini, I. Eberini, S. Daniele, C. Sensi, M.L. Trincavelli, C. Martini, M.P. Abbracchio (Milano, Pisa) |
| P-5/74 | Acetyl-L-carnitine, a new
pharmacological modulator of adult hippocampal neurogenesis in vitro. M.M. Valente, V. Bortolotto , PL. Canonico , A. Koverech, M. Grilli (Novara , Novara, Pomezia ) |
| P-5/75 | Alpha2-delta ligands as novel
positive modulators of adult mouse neurogenesis in vitro and in vivo. V. Bortolotto, M.M. Valente, V. Meneghini, PL. Canonico, M. Grilli (Novara) |
| P-5/76 | Serotonin involvement in beneficial effects of Rhodiola rosea in the attenuation of nicotine withdrawal signs in rats C. Mannucci, M. Navarra, A. Pieratti, E. Calzavara, A.P. Caputi, G. Calapai (Messina) |
| P-5/77 | Purine nucleoside phosphorylase
(PNP) is released from cultured rat astrocytes and microglial cells by
lysosomal exocytosis. E. Polazzi, B. Monti, I. Mengoni, P. Giuliani, S. Buccella, S. Cicchitti, F. Caciagli, A. Poli (Bologna, Chieti) |
| P-5/78 | Deregulation of calcium signaling in hippocampal astrocytes in TAT-PRO
model of Alzheimer’s disease D. Lim, A. Grolla, E. Marcello, F. Gardoni, M. Di Luca, PL. Canonico, A.A. Genazzani (Novara, Milano) |
| P-5/79 | Soluble beta
amyloid and its effect on HPA axis function M.G. Morgese, S. Schiavone, L. Trabace, V. Cuomo (Foggia, Ginevra, Roma) |
| P-5/80 | Involvement of nitric
oxide in noradrenergic alteration induced by acute soluble beta amyloid M. Colaianna, L. Ciuffreda, L. Trabace, V. Cuomo (Foggia, Roma) |
| P-5/81 | ADAM10
regulates spine morphology and glutamate receptor
composition through N-Cadherin cleavage M. Malinverno, F. Gardoni, M. Carta, R. Epis, E. Marcello, C. Verpelli, F. Cattabeni, C. Sala, C. Mulle, M. Di Luca (Milan, Bordeaux) |
| P-5/82 | Toxicity of amyloid beta on embryo rat neuronal cells is mediated
by Tumor Necrosis Factor Related Apoptosis Inducing Ligand G. Di Benedetto, N. Ronsisvalle, N. Landolina, R. Bernardini, G. Cantarella (Catania) |